Uniphos Enterprises Ltd – The ₹1,800 Cr UPL Stake That’s More Alive Than Its Business
Date of Publishing -
Spotted a factual error — a wrong number, date, or fact? Tell us and we will check the source.
🧠 At a Glance
Uniphos Enterprises looks like a zombie stock on paper – barely any operations, zero growth, and negative profits. But surprise: it owns a ₹1,800 Cr stake in UPL, making its market cap of ₹1,082 Cr look like a bad joke. Is this the ultimate hidden holding company arbitrage?
1. 🪦 WTF Do They Even Do?
UEL is registered as a Core Investment Company (CIC).
Technically, it “trades chemicals” – but that’s like saying Baba Sehgal is still dropping chartbusters.
Its real business is this:
Owns 3.95 Cr shares of UPL Ltd (5.17%)
That’s worth ₹1,801 Cr, as of FY25
Versus Uniphos’ own market cap of ₹1,082 Cr
Yes, it’s trading at a 40% discount to just its UPL stake 🤯
2. 📉 Financials – Bad, Worse, Worst
Metric
FY23
FY24
FY25
Revenue
₹1 Cr
₹51 Cr
₹112 Cr
EBITDA
-₹3 Cr
-₹3 Cr
-₹4 Cr
Net Profit
₹39 Cr
₹39 Cr
₹0 Cr
Dividend
₹0.50/share (FY25)
Payout: 1242% of earnings 🤡
–
ROE
0.01%
0%
0%
FY25 profit basically flatlined to zero
All past profits were from other income – not real operations
